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Background. The mechanisms of immunity to Rickettsia conorii that have been elucidated in mouse models
have not been evaluated in human tissues.
Methods. In this study, quantitative real-time polymerase chain reaction was used to determine the levels of
expression of inflammatory and immune mediators in skin-biopsy samples collected from 23 untreated patients
with Mediterranean spotted fever (MSF).
Results. In all 23 patients, the levels of intralesional expression of mRNA of tumor necrosis factor (TNF)–a,
interferon (IFN)–g, interleukin (IL)–10, RANTES, and indoleamine-2,3-dioxygenase (IDO), an enzyme involved
in limiting rickettsial growth by tryptophan degradation, were higher than those in control subjects; 6 of the 23
patients had high levels of inducible nitric oxide synthase (iNOS), a source of microbicidal nitric oxide. Positive
correlations between TNF-a, IFN-g, iNOS, IDO, and mild/moderate MSF suggest that type 1 polarization plays
a protective role. Significantly higher levels of intralesional expression of IL-10 mRNA were inversely correlated
with levels of intralesional expression of IFN-g mRNA and TNF-a mRNA. The mRNA-expression level of the
chemokine RANTES was significantly higher in patients with severe MSF.
Conclusion. Mild/moderate MSF is associated with a strong and balanced intralesional proinflammatory and
anti-inflammatory response, with a dominant type 1 immunity, whereas severe MSF is associated with increased
expression of chemokine mRNA. Whether these factors are simply correlates of mild and severe MSF or contribute
to antirickettsial immunity and pathogenesis remains to be determined.
Mediterranean spotted fever (MSF) is an acute, febrile,
tick-transmitted rickettsiosis caused by Rickettsia co-
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norii [1]. Rickettsia replicates in the cytoplasm of en-
dothelial cells, eliciting widespread vasculitis, hypoper-
fusion, and multiple-organ injury associated with in-
creased vascular permeability [2]. Although effec-
tively treated with doxycycline, severe and fatal MSF
occurs due to misdiagnosis or late initiation of treat-
ment [3, 4].
Serum cytokines associated with T cell activation are
observed in spotted-fever group (SFG) rickettsioses [5,
6]. Although local cutaneous immune responses to MSF
have been studied by histopathological and immuno-
histochemical analysis, other immune and inflamma-
tory mediators that could play an important role either
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Table 1. Clinical and laboratory data on patients with severe Mediterranean spotted fever.
Characteristic Patient 4 Patient 7 Patient 15 Patient 16 Patient 17
Age, years 83 50 60 61 81
Sex Male Male Male Female Female
Leukocyte count, no./mL 13,300 … 6900 29,300 21,000
Hemoglobin, g/dL 12.5 … 12.6 11.4 10.8
Lymphocytes, no./mL 7500 5300 4200 5500 11,200
Platelets, no./mL 127,000 74,000 103,000 193,000 94,000
Liver enzymes
Alanine aminotransferase, U/L 38 262 207 191 213
Aspartate aminotransferase, U/L 227 196 149 377
Hepatomegaly/splenomegaly Yes/no No/no
Renal-function tests
Creatinine, mg/dL 2.7 1.3 3.8 0.8 1.2
Urea, mg/dL 48 47 8
Admission to intensive-care unit? No No Yes Yes No
Hypoxemiaa Yes Yes No No No
Arterial blood gases
pH 7.45 7.47
PCO2, mmHg 34.1 9.1
PO2, mmHg 65 48
HCO3, mmol/dL 23 106
Pneumonitis Yes
Neurological signs
Confusion Yes Yes Yes Yes Yes
a As determined by pulmonary-function test.
in protection against rickettsial infection or in the pathogenesis
of MSF remain to be characterized [7].
In vitro studies have shown that intracellular killing of R.
conorii within human endothelium, macrophages, and hepa-
tocytes is mediated by either 1 or a combination of 3 mech-
anisms involving nitric oxide, hydrogen peroxide, and tryp-
tophan degradation [8]. Human hepatocytes stimulated by
interferon (IFN)–g, tumor necrosis factor (TNF)–a, interleukin
(IL)–b, and RANTES kill intracellular rickettsiae by a nitric
oxide–dependent mechanism. Human macrophages and mono-
cytes activated by cytokines kill intracellular rickettsiae by a
hydrogen peroxide–dependent mechanism and, via expression
of the tryptophan-degrading enzyme indoleamine-2,3-dioxy-
genase (IDO), by limitation of the availability of tryptophan.
It is not known (1) whether these effector molecules are pro-
duced in humans and (2) whether the production of these
molecules is dependent on a particular cytokine and chemokine
environment.
IFN-g and TNF-a have been associated with a favorable
outcome in our in vitro and in vivo murine studies of rickettsial
infection [9]. Th1 responses, characterized by the production
of IFN-g (which favors not only the activation of microbicidal
mechanisms of macrophages and other infected target cells but
also the differentiation of B cells for production of Th1 isotype
antibody) together with the activation of antigen-specific cy-
totoxic CD8+ T cells, appear to be protective [9, 10]. It is not
known whether Th2 responses, characterized by the production
of IL-4 and/or IL-10, play no role or have a detrimental effect.
Also, it is not known whether immunopathological conditions
play a role in human rickettsial infections. To determine the
local immune and inflammatory responses at sites of rickettsial
infection, we prospectively studied Portuguese patients with
MSF. We examined the mRNA-expression levels of TNF-a,
RANTES, IFN-g, IL-10, IDO, and inducible nitric oxide syn-
thase (iNOS), which are critical molecules in antirickettsial im-
mune responses [8–12], in skin-biopsy samples from patients
with MSF that were collected 3–14 days after onset of fever.
The mRNA-expression levels of TNF-a, IFN-g, RANTES, IDO,
and iNOS in these patients were significantly greater than those
in the control subjects.
SUBJECTS AND METHODS
Human Subjects
Patients with a clinical diagnosis of MSF who were admitted
to hospitals in Portugal were included in the study. The initial
diagnosis of MSF was based on clinical signs, fever, rash, and/
or eschar, with or without myalgias, headache, leukopenia,
thrombocytopenia, and elevated levels of hepatic enzymes. In
some cases, data on history of tick exposure, outdoor activities,
and animal contact were obtained. The diagnosis was confirmed
on the basis of detection of anti-Rickettsia antibodies, by im-
munofluorescence assay (IFA), and/or of Rickettsia organisms
or DNA in blood, by culture or polymerase chain reaction
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Table 2. Primers and probes used in real-time reverse transcriptase–polymerase chain reaction of cytokines, chemokine,
and microbicidal enzyme genes, in patients with Mediterranean spotted fever.
Cytokines and chemokine (method) Primer and probe sequences
RANTES (Quantitect Gene Expression Assay) Hs_CCL5_1_FAM
iNOS (Quantitect Gene Expression Custom Assay) Forward, 5′-GCACATTCAGATCCCCAA-3′
Reverse, 5′-CATGCTGCTGAGGGCTTT-3′ (probe CACCACTACAGGCTCGT)
IDO (Quantitect Gene Expression Custom Assay) Forward, 5′-TATATGCCACCAGCTCAC-3′
Reverse, 5′-GGCCAGCATCACCTTTTG-3′ (probe GTCAAATCCCTCAGTCC)
TNF (Quantitect Gene Expression Assay) Hs_TNF_1_FAM
IFN-g (Quantitect Gene Expression Assay) Hs_ IFN-g _1_FAM
IL-10 (Quantitect Gene Expression Assay) Hs_IL-10_1_FAM
GAPDH (Quantitect Gene Expression Assay) Hs_GAPDH_1_FAM
NOTE. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IDO, indoleamine-2,3-dioxygenase; IL, interleukin; IFN, interferon; iNOS, inducible
nitric oxide synthase; TNF, tumor necrosis factor.
(PCR), or DNA in skin, by PCR. For each patient, epidemi-
ological and clinical data were recorded on a standardized form.
The severity of MSF was scored on the basis of either ad-
mission to the intensive-care unit (ICU) or evidence of hepatic
injury, respiratory or renal insufficiency, or hematological or
neurological involvement. Hepatic injury was defined as ele-
vated (1100 U/L) serum levels of alanine aminotransferase
(ALT). Respiratory insufficiency was defined as hypoxemia (ar-
terial Po2 !70 mmHg), and renal insufficiency was defined as
a serum level of creatinine that was1.8 mg/dL). Neurological
involvement was characterized by confusion. Hematological
involvement was defined as either mild/moderate (120,000–
150,000 platelets/mL) or severe (!120,000 platelets/mL) throm-
bocytopenia with or without anemia and/or leukopenia. Of the
23 patients with MSF, 5 were considered to represent severe
cases (table 1), on the basis of either involvement of 3 organ
systems or admission to the ICU (in the case of 2 patients),
whereas 7 were considered to represent moderately severe cases,
on the basis of involvement of 2 organ systems; the remaining
11 patients were considered to represent mild cases, on the
basis of involvement of only 1 organ system.
Sample Collection
Blood samples were collected from the patients both at their
initial visit to the clinic or admission to hospital (2–7 days after
onset of symptoms; mean, 5 days) and at follow-up (14–21
days after onset of symptoms; mean, 15 days). Blood was cen-
trifuged to separate serum or plasma, for IFA, and peripheral
mononuclear cells (buffy coat), for culture. Samples were stored
at 80C until processed.
Skin-Biopsy Samples
At admission, skin punch–biopsy samples (diameter, 5 mm)
were obtained from the 23 patients and 8 control subjects.
Control skin-biopsy samples were obtained from discarded skin
tissues from patients admitted for surgical treatment of inguinal
hernia. In these latter patients, rickettsial infection was excluded
by either serological analysis or PCR performed on the skin
tissues. Informed consent was obtained from all subjects, and
the experiments were performed with the approval of the ethical
committees of the hospitals and the National Institute of
Health. Before treatment, 20 skin-biopsy samples were obtained
from eschars, and 3 were obtained maculopapular rashes.
Laboratory Confirmation of MSF
Serological analysis. Testing of acute and convalescent sera
confirmed the diagnosis of R. conorii infection when (1) sam-
ples of acute serum contained IgM antibodies at a titer of 32
and/or IgG antibodies at a titer of 128 (on the basis of
cutoff values established by the National Institute of Health
for the Portuguese population) or (2) there was a 4-fold in-
crease between the titer for acute serum and that for con-
valescent serum [13, 14].
Isolation. Isolation of Rickettsia from patients’ blood, as
well as strain identification, were performed as described else-
where [15].
Detection of Rickettsia in skin-biopsy samples by PCR.
DNA was extracted from the skin samples by use of a DNeasy
Tissue Kit (Qiagen). PCR, nested-PCR, and rickettsial-strain
characterization were performed as described elsewhere [16].
Detection of Immune-Response Markers in Skin Samples
by Real-Time Quantitative Reverse Transcriptase (RT)–PCR
Total RNA was extracted from skin-biopsy samples by an or-
ganic extraction method using the RNaqueous Kit (Ambion).
Samples were treated with DNase (DNA-free; Ambion). Ex-
tracted RNA was quantified, and the ratio of the absorbance
values at wavelengths 260 nm and 280 nm was used to estimate
the purity of the RNA.
Quantitative real-time RT-PCR assayed the mRNA expres-
sion of RANTES, TNF-a, IFN-g, IL-10, IDO, iNOS, and the
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), using the iCycler iQ Multicolor Real-Time Detec-
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Table 3. Demographics, detection of Rickettsia-specific IgM and IgG antibodies in serum
samples by immunofluorescence assay (IFA), and results of rickettsial isolation from blood
of skin biopsy based on polymerase chain reaction (PCR), in patients with Mediterranean
spotted fever.
Patient (age,
years [sex])
Blood
isolation
Days between
onset of
fever and
skin biopsy
Skin
PCR
IFA results
Acute phase
Convalescent
phase
Day
Titer
IgM/IgG Day
Titer
IgM/IgG
1 (20 [male]) Neg 7 Pos 7 Neg/Neg NA
2 (54 [female]) Neg 2 Pos 5 Neg/Neg 8 128/1024
3 (44 [female]) Neg 5 Pos 6 Neg/Neg NA
4 (83 [male]) Neg NA Pos NA Neg/Neg NA
5 (49 [female]) Neg 6 Pos 6 Neg/Neg NA
6 (67 [female]) Neg 3 Pos 3 128/1024 NA
7 (50 [male]) Pos 6 Pos 6 Neg/Neg 14 1024/4096
8 (30 [male]) Neg 8 NA 8 32/256 24 64/2048
9 (55 [female]) NA 8 NA 14 1024/4096 NA
10 (49 [male]) Neg 2 NA 6 32/Neg NA
11 (42 [male]) Neg 10 NA 10 Neg/512 NA
12 (29 [male]) Neg 10 NA 10 512/512 NA
13 (48 [male]) Pos 8 NA 8 Neg/Neg NA
14 (67 [female]) Neg 5 NA 5 Neg/Neg 14 1024/4096
15 (60 [male]) Neg 3 Pos 3 32/Neg 11 1024/4096
16 (61 [female]) Pos 3 Pos 3 Neg/Neg 17 1024/4096
17 (81 [female]) Pos NA Pos NA 128/256 NA
18 (42 [female]) NA 4 NA 4 Neg/Neg 20 128/2048
19 (81 [female]) Neg 5 Pos 5 Neg/Neg 7 32/Neg
20 (81 [female]) Neg NA Pos NA Neg/Neg NA
21 (75 [female]) Neg NA Pos NA 32/4096 NA
22 (63 [female]) Neg 5 NA 5 Neg/Neg 17 64/1024
23 (69 [female]) Neg 12 NA 13 128/1024 NA
NA, not available; Neg, negative; Pos, positive.
tion system (Bio-Rad) in combination with the QuantiTect
Probe RT-PCR Gene Expression kit (Qiagen)
The primers and probes used in the present study (Qiagen)
are shown in table 2. Amplifications and the thermal-cycler
parameters used followed the manufacturer’s recommenda-
tions. Each sample was analyzed in duplicate, and the average
was used to calculate relative mRNA expression. We used the
delta-delta method (i.e., comparative CT [DCT] method) for
quantitative analysis of gene expression [17]. The results were
normalized to those for GAPDH in the same sample and were
expressed as copy number per 10,000 GAPDH copies.
Statistical Analysis
Data analysis was performed by use of frequency distributions
and central-tendency measures. Comparison of frequencies be-
tween groups of patients was evaluated by x2 test or Fisher’s
exact test. The Mann-Whitney and Kruskal-Wallis tests were
used to compare distributions, allowing us to examine the re-
lation between the mRNA levels of different cytokines and their
association with the severity of MSF. Correlations between cy-
tokines were analyzed on the basis of Spearman and Pearson’s
correlation coefficients, allowing us to examine the relation
between the mRNA levels of different cytokines and their cor-
relation with the severity of MSF. was regarded as beingP ! .05
statistically significant.
RESULTS
Study Population and Clinical Data
The clinical diagnosis of MSF in the 23 patients in the present
study was confirmed by serological analysis and/or rickettsial
isolation and/or PCR-based detection of rickettsial DNA in
skin-biopsy samples (table 3); 2 of these patients (9%) were
treated as outpatients, and the remaining 21 patients (91%)
were admitted to the hospital, where 2 of them (9%) subse-
quently were transferred to the ICU. Epidemiological, clinical,
and laboratory data are presented in tables 4 and 5.
The levels of aspartate aminotransferase (AST) in patients
with severe MSF were significantly higher than those in patients
with mild/moderate MSF (mean levels of AST were 211 U/L
and 58 U/L, respectively; ). Although ALT levels in pa-Pp .01
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Table 4. Epidemiological and clinical features of patients with Medi-
terranean spotted fever.
Epidemiological and clinical features Men
(n p 9)
Women
(n p 14)
Age, mean (95% CI), years 45.7 (31.2–60.1) 63.5 (55.8–71.2)
Animal contact 5 (56) 11 (79)
Tick-bite history 7 (78) 12 (86)
Month at onset
May 1 2
June 0 3
July 4 4
August 3 5
September 1 0
Time between first symptoms and
admission, mean (95% CI), days 6.6 (4.2–8.9) 5.3 (3.4–7.2)
Duration of hospitalization, mean
(95% CI), days 7.8 (3.4–12.3) 5.6 (3.9–7.4)
Rash 9 (100) 13 (93)
Fever 9 (100) 14 (100)
Eschar 6 (67) 14 (100)
NOTE. Data are no. (%) of patients, unless otherwise specified. CI, confidence
interval.
tients with severe MSF were higher than those in patients with
mild/moderate MSF, the difference was not statistically signif-
icant (mean levels of ALT were 207 U/L and 82 U/L, respec-
tively; )Pp .17
Risk factors that could potentially be associated with mod-
erate/severe MSF included diabetes mellitus (1 patient), alco-
holism (2 patients), age 65 years (8 patients), and coronary
artery disease (1 patient). Also, 2 patients had HIV and hepatitis
C virus (HCV) infection; both of them were receiving antiret-
roviral and anti-HCV therapy and had very low viral loads.
High mRNA-Expression Levels of TNF-a, IL-10, IFN-g, RANTES,
IDO, and iNOS, in Skin from Patients with MSF
The expression of TNF-a mRNA in the patients with MSF was
significantly higher ( ) than that in the control subjects.P ! .0007
The median TNF-a mRNA-expression in the patients with MSF
was ∼10,000 copies, compared with 3300 copies in the control
subjects (figure 1A). The mRNA-expression levels of IL-10,
IFN-g, RANTES, and IDO showed similar patterns: levels in
the patients with MSF were significantly higher ( ) thanP ! .0001
those in the control subjects; the median copy numbers of these
different cytokines’ mRNA in the patients with MSF versus the
healthy control subjects were as follows: IL-10, 3434 versus 287;
IFN-g, 860 versus 5; RANTES, 13,736 versus 1187; and IDO,
2888 versus 43 (figure 1B–1E). In 17 of the patients with MSF,
the mean mRNA-expression levels of iNOS were comparable
to those in the control subjects (copy numbers 687 and 760,
respectively) (figure 1F); in the remaining 6 patients, the levels
were significantly higher than those in the control subjects.
Taken together, these data suggest that rickettsial infection is
associated with increased expression of several immune and
inflammatory mediators in the skin of patients with MSF, with
a trend toward mixed type 1, proinflammatory, and anti-in-
flammatory responses.
Correlations between mRNA-Expression Level of TNF-a, IFN-g,
and IL-10
The critical factors responsible for immunoregulation in par-
ticular infections, as well as the variation in response and out-
come between different patients, are determined by the balance
between pro- and anti-inflammatory mediators [18–21]. To
determine whether such an immunoregulatory mechanism ex-
isted in the patients in the present study, we compared the
mRNA-expression levels of pro- and anti-inflammatory cyto-
kines. We observed nonlinear relationships between the mRNA-
expression levels of TNF-a and IL-10 (figure 2A), as well as
between those of IFN-g and IL-10 (figure 2B). In 67% of the
patients with MSF, a significantly ( ) positive correlationP ! .05
was detected between the 3800-copies expression level of IL-
10 mRNA and an elevated level of TNF-a mRNA; in contrast,
in 33% of the patients with MSF, a significantly negative cor-
relation was observed between a high (13800 copies) level of
IL-10 mRNA expression and a low level of TNF-a mRNA
expression. Similarly, in 73% of the patients with MSF, the
5000-copies level of IL-10 mRNA expression correlated with
elevated IFN-g mRNA expression (figure 2B), whereas an el-
evated (15000 copies) level of IL-10 mRNA expression corre-
lated with down-regulation of IFN-g mRNA ( ). ThesePp .06
data suggest the presence of an immunoregulatory mechanism,
mediated by anti-inflammatory IL-10, that can help to avoid
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Table 5. Laboratory findings on the day of admission, in patients with
Mediterranean spotted fever.
Abnormal laboratory results Males Females
Anemia !11 g/dL 0 2 (15)
Leukopenia !4400 cells/mL 1 (11) 4 (29)
Leukocytosis 111,300 cells/mL 1 (11) 1 (8)
Thrombocytopenia
Mild/moderate (120,000–159,000 PLTs/mL for males;
120,000–149,000 PLTs/mL for females) 1 (11) 5 (36)
Severe (120,000 PLTs/mL) 5 (56) 4 (29)
Renal failure (creatinine 1.8 mg/dL) 2 (9) 0
Hepatocellular injury
Alanine aminotransferase (ALT)
Mild/moderate (41–100 U ALT/L for males;
31–100 U ALT/L for females) 3 (38) 5 (36)
Severe (ALT 1100 U/L) 3 (38) 7 (50)
Aspartate aminotransferase (AST)
Mild/moderate (37–100 U AST/L for males;
31–100 U AST/L for females) 2 (29) 8 (62)
Severe (1100 U AST/L) 4 (57) 4 (31)
NOTE. Data are no. (%) of patients for whom data were available. PLTs, platelets.
severe tissue damage due to excess intralesional production of
proinflammatory and type 1 cytokines.
Local Production of High mRNA-Expression Levels of TNF-a
and IFN-g: Frequent Association with High mRNA-Expression
Levels of iNOS and IDO
In the patients with MSF, a significant ( ) positive cor-Pp .028
relation was observed between the level of IFN-g mRNA ex-
pression and that of iNOS mRNA, as well as between the level
of IFN-g mRNA expression and that of IDO mRNA (figure
2C and 2D), correlations that were not observed in the control
subjects (data not shown). In most of the patients with mild
or severe MSF, higher levels of IFN-g mRNA expression cor-
related with higher levels of iNOS mRNA expression and of
IDO mRNA expression. In the patients with MSF, a similarly
significant ( ) positive correlation was observed be-Pp .002
tween the mRNA-expression levels of TNF-a and those of iNOS
and of IDO (figure 2E and 2F), a correlation that was not
observed in the control subjects (data not shown). These data
suggest that TNF-a and IFN-g play a protective role in rick-
ettsial diseases in humans, via activation of intracellular bac-
tericidal mechanisms.
Local Production of High Levels of TNF-a mRNA: Association
with High Levels of IFN-g mRNA
In the patients with MSF, a significant ( ) positivePp .0001
correlation was observed between the level of TNF-a mRNA
expression and that of IFN-g mRNA expression (figure 3A), a
correlation that was not observed in the control subjects (figure
3B). These results suggest that TNF-a and IFN-g have poten-
tially synergistic effects with respect to the activation of intra-
cellular bactericidal effector mechanisms.
Comparison of mRNA-Expression Levels of TNF-a, IL-10, IFN-g,
RANTES, iNOS, and IDO, in Mild, Moderate, and Severe MSF
To assess the contribution that pro- and anti-inflammatory
mediators make to the development of mild and severe MSF,
we examined the mRNA-expression levels of IFN-g, TNF-a,
IL-10, RANTES, iNOS, and IDO in patients with mild, mod-
erate, or severe MSF. Although the median mRNA-expression
levels of IFN-g, TNF-a, IL-10, iNOS, and IDO were not sta-
tistically significantly different between patients with these 3
differing severities of illness (table 6), our data demonstrated
a trend toward expression of substantially high levels of certain
biomolecules in either mild or severe MSF (table 7): TNF-a
mRNA-expression levels of6500 copies were detected in 64%,
86%, and 100% of patients with mild, moderate, and severe
MSF, respectively; in contrast, IFN-g mRNA-expression levels
of500 copies were detected in 45%, 57%, and 20% of patients
with mild, moderate, and severe MSF, respectively. All patients
with severe MSF had very high IDO mRNA-expression levels
(1500 copies), compared with only 45% of patients with mild
MSF; in contrast, 800 copies of iNOS mRNA were expressed
in 45% of patients with mild MSF, whereas similar levels were
expressed in only 14% and 20% of patients with moderate and
severe MSF, respectively. The level of IL-10 mRNA expression
was comparable in all 3 groups of patients: levels of 3000
copies were detected in 64%, 43%, and 60% of patients with
mild, moderate, and severe MSF, respectively. All of the patients
with severe MSF had high RANTES mRNA-expression levels
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Figure 1. mRNA levels of cytokines and a chemokine: tumor necrosis factor (TNF)–a (A), interleukin (IL)–10 (B), interferon (IFN)–g (C), RANTES
(D), indoleamine-2,3-dioxygenase (IDO) (E), and inducible nitric oxide synthase (iNOS) (F), in patients with Mediterranean spotted fever (Cases) and in
control subjects (Controls), quantified by real-time reverse-transcriptase polymerase chain reaction. Cycle threshold values for genes of interest were
normalized to those for glyceraldehyde-3-phosphate dehydrogenase and were used to calculate the relative extent of mRNA expression. The tops and
bottoms of the shaded boxes denote the 25th and 75th percentiles, respectively, and the horizontal line within each of the boxes denotes the median
value; dots denote outliers.
(10,000 copies), an expression level that was close to being
significantly higher in patients with severe MSF than in patients
with mild or moderate MSF (table 7).
DISCUSSION
Most of our understanding of immune responses in rickettsial
diseases stems from murine models of disseminated spotted-
fever rickettsiosis. Few studies in patients with rickettsial dis-
eases have examined the levels of pro- and anti-inflammatory
and immune mediators in the sera of such patients. However,
no previous human studies directly examined either the local
mediators of inflammation or the immune response at the site
of infection (e.g., skin) in rickettsial diseases. The present study
is, to our knowledge, the first comprehensive study of intra-
lesional expression of cytokine and chemokine transcripts in
patients with MSF. Certain patterns are evident in the study’s
results. First, the data revealed mixed type 1, proinflammatory,
and anti-inflammatory responses, as reflected by elevated levels
of mRNA expression of IFN-g, TNF-a, and IL-10 in patients
with MSF. The correlation between elevated intralesional ex-
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Figure 2. Correlation between mRNA-expression levels of tumor necrosis factor (TNF)–a and interleukin (IL)–10 (A), interferon (IFN)–g and IL-10 (B),
IFN-g and inducible nitric oxide synthase (iNOS) (C), IFN-g and indoleamine-2,3-dioxygenase (IDO) (D), TNF-a and iNOS (E), and TNF-a and IDO (F).
pression of IFN-g mRNA, particularly in patients with mild/
moderate MSF, and the absence of rickettsiae in the blood
suggests that there is an IFN-g–mediated reduction in bacterial
load in these patients. Second, the data demonstrate a positive
correlation between high levels of IFN-g mRNA and TNF-a
mRNA and the production of enzymes involved in limiting
microbial growth—enzymes such as iNOS [22–24] and IDO
[8, 25]—in the patients with MSF but not in the control sub-
jects. Both iNOS and IDO are produced by many types of innate
immune cells, in response to either bacterial endotoxins or
proinflammatory and Th1 cytokines such as TNF-a and IFN-
g [25–32]. Thus, the correlation, in these patients with MSF,
between elevated mRNA expression of IFN-g and TNF-a and
mRNA expression of iNOS and IDO suggests that IFN-g and
TNF-a play a synergistic role in the induction of iNOS and
IDO.
The data in the present study show that some patients de-
veloped moderate/severe MSF in spite of significantly higher
mRNA levels of dermal TNF-a and, to a lesser extent, of dermal
IFN-g. On the basis of these data, we propose 2 potential
mechanisms that could account for the development of severe
MSF. First, the simultaneous expression of higher levels of im-
munosuppressive IL-10 mRNA may decrease responsiveness to
IFN-g. IL-10 is associated with disease progression or with
counteracting the IFN-g– and TNF-a–mediated activation of
intracellular microbicidal mechanisms [29, 30]. Analysis of the
serum cytokine profile in Sicilian patients with MSF has also
suggested that IL-10 plays a Th1-inhibitory role [6]. In addition,
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Figure 3. A, Correlation between mRNA-expression levels of tumor
necrosis factor (TNF)–a and interferon (IFN)–g, in patients with Medi-
terranean spotted fever (MSF). In these patients, there was a significant
positive ( ) correlation between the level of TNF-a mRNA ex-Pp .0001
pression and that of IFN-g mRNA expression, a correlation that was not
observed in the control subjects (data not shown). B, Comparison between
the level of RANTES mRNA expression in patients with mild/moderate
MSF and that in patients with severe MSF. The level of expression of
RANTES mRNA is close ( ) to being significantly higher in patientsPp .073
with severe MSF than in patients with mild/moderate MSF. The tops and
bottoms of the shaded boxes denote the 25th and 75th percentiles,
respectively, and the horizontal line within each of the boxes denotes
the median value; dots denote outliers.
the production of Th1-promoting cytokines, such as IL-12, by
peripheral blood mononuclear cells from patients with MSF
was enhanced in vitro by the addition of either recombinant
IFN-g or anti–IL-10 monoclonal antibodies [33]. Second, un-
balanced pro- and anti-inflammatory cytokine responses with
higher levels of TNF-a were observed in patients with severe
MSF. This immunopathological condition represents disease
manifestations that are caused by the immune system while the
latter is attempting to control infection. The present study does
not provide direct evidence for immunopathological condition
in rickettsial disease. However, previous immunohistochemical
and histopathological analyses of eschars either from fatal cases
of Rocky Mountain spotted fever (RMSF) or from patients with
MSF suggest the possibility that immune-mediated pathological
mechanisms are present in MSF [7, 34, 35]. This hypothesis is
based on 3 main features: (1) the eschars from patients with
RMSF contained a massive quantity of rickettsiae in the en-
dothelium and vascular smooth-muscle cells of the blood ves-
sels, whereas very few organisms were present in the eschars
from patients with MSF; (2) abundant lymphohistiocytic in-
filtrates, mainly T lymphocytes, were observed in lesions from
patients with MSF; and (3), compared with the cutaneous ne-
crosis in eschars from patients with RMSF and the association
between such necrosis and occlusive thrombosis, the eschar
lesion in patients with MSF was associated with dermal edema,
edema of the vascular wall, and endothelial swelling [7, 34, 35].
Thus, the occurrence of moderate/severe vascular injury and
cutaneous necrosis in MSF, in the absence of occlusive throm-
bosis and overwhelming infection but in the presence of abun-
dant lymphohistiocytic infiltration, suggests the possibility of
an immunopathological mechanism of the lesion. Moreover,
the absence of rickettsiae in the blood of patients with severe
MSF (table 3) further supports the hypothesis that severe MSF
could be due to an immunopathological condition rather than
to an overwhelming infection. On the basis of the aforemen-
tioned data, we postulate that balanced pro- and anti-inflam-
matory cytokines mediate protective type 1 immunity against
Rickettsia while avoiding an immunopathological condition.
In the present study, we have also analyzed the mRNA-ex-
pression levels of IFN-g, TNF-a, iNOS, IDO, RANTES, and
IL-10 in 3 groups of patients—those with mild, moderate, or
severe MSF. The data do not show statistically significant dif-
ferences, in median levels of expression of these biomolecules,
between these 3 groups of patients; however, this could be due
to (1) the multifunctionality of many biomolecules, (2) wide-
spread interactions between them, differences in the timing of
when samples were obtained, and (3) the fact that local immune
responses in the skin of patients with systemic rickettsial dis-
eases may not exactly reflect the severity of overall illness. De-
spite these confounding factors, certain patterns are evident.
First, IFN-g is critical for protection against severe MSF, and
that protection is dependent on expression of iNOS mRNA
(table 7). The data in the present study are consistent with the
protective role played by IFN-g in animal models of SFG rick-
ettsiosis [10, 36]; however, they are in disagreement with the
results of a previous study [5], which showed that IFN-g was
absent in acute and convalescent plasma samples from patients
with African tick-bite fever (ATBF), an SFG rickettsiosis caused
by R. africae. These discordant results could be due to the
possibility that cutaneous, rather than systemic, production of
IFN-g is the better indicator of protection against Rickettsia.
Second, in the present study, high (6500 copies) levels of
TNF-a mRNA were detected in only 64% of patients with mild
MSF, whereas they were detected in 100% of patients with
severe MSF. These data suggest that TNF-a plays a dual role,
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Table 6. Median levels of mRNA expression of cytokines, in patients with mild, mod-
erate and severe Mediterranean spotted fever (MSF).
Cytokines and
chemokine
Mild MSF
(n p 11)
Moderate MSF
(n p 7)
Severe MSF
(n p 5) Pa
IFN-g .381
Median 238.1 721.9 230.0
Interquartile range 132.1–1905.1 293.2–1256.9 230.0–361.0
Total range 23.4–9712.9 157.1–1777.6 103.7–1094.2
TNF-a .930
Median 9712.9 11,958 10,055.4
Interquartile range 5388.6–22,314.3 8753.7–18,764.0 7620.6–17,507.8
Total range 3204.0–70,029.9 3555.1–20,820.0 7360.9–20,820.0
iNOS .879
Median 628.5 673.6 628.5
Interquartile range 493.1–1347.1 283.2–1972.3 246.5–721.9
Total range 238.1–6634.0 43.6–3204.0 123.3–2345.5
IDO .423
Median 1301.3 3944.7 3944.7
Interquartile range 586.4–2789 460.1–25,632 2888.0–9712.9
Total range 528.5–86,217 274–83,280 1214.1–16,335
IL-10 .785
Median 3680.5 3204.1 3317
Interquartile range 2605.0–5027.7 2989.5–5027.7 1602.0–4083.8
Total range 1547.5–7110.2 888.8–8753.7 1301.3–5388.6
RANTES .073
Median 14,722.0 8753.8 17,507.5
Interquartile range 8167.5–23,101.3 5578.6–13,268.2 16,911.1–24,759.3
Total range 4856.4–56,881.9 5388.6–23,101.3 10,410.0–38,851.5
NOTE. IDO, indoleamine-2,3-dioxygenase; IL, interleukin; IFN, interferon; iNOS, inducible nitric oxide
synthase; TNF, tumor necrosis factor.
a Kruskal-Wallis test
Table 7. Levels of mRNA expression of cytokines, above an
established cutoff value, in patients with mild, moderate, and
severe Mediterranean spotted fever (MSF).
Cutoff values of cytokines
and chemokine
Mild
MSF
Moderate
MSF
Severe
MSF Pa
IFN-g 500 copies 5 (45) 4 (57) 1 (20) .556
TNF-a 6500 copies 7 (64) 6 (86) 5 (100) .439
iNOS 800 copies 5 (45) 1 (14) 1 (20) .1
IDO 1500 copies 5 (45) 4 (57) 5 (100) .277
IL-10 3000 copies 7 (64) 3 (43) 3 (60) .146
RANTES 10,000 copies 7 (64) 3 (43) 5 (100) .137
NOTE. Data are no. (%) of cases, in indicated group. IDO, indoleamine-
2,3-dioxygenase; IL, interleukin; IFN, interferon; iNOS, inducible nitric oxide
synthase; TNF, tumor necrosis factor.
a By Fisher’s exact test.
being involved in both protective antirickettsial immunity and
the pathogenesis of severe MSF. Supporting this conclusion are
the results of a previous study [6], which has demonstrated
high plasma levels of TNF-a in acute serum from patients with
ATBF, levels that, on follow-up, subsequently decreased to levels
that were comparable to those in control subjects. Third, the
present study revealed expression of high levels of RANTES
mRNA in all patients with MSF, in contrast to what was ob-
served in the control subjects, with significantly higher ex-
pression in patients with severe MSF than in those with mild/
moderate MSF (figure 3B). RANTES is a chemokine that me-
diates the trafficking and homing of several lymphoid and my-
eloid cells, such as T cells, monocytes, and dendritic cells, to-
ward the site of infection [37]. The expression of RANTES
mRNA in the skin of patients with MSF could therefore explain
the presence of prominent perivascular cellular infiltration in
SFG rickettsiosis [7, 10, 34, 38]. The data in the present study
also suggest that, like TNF-a, RANTES plays a dual role, being
involved in both antirickettsial immunity and the pathogenesis
of severe MSF. The protective role of RANTES could be due
to RANTES-mediated chemotaxis of IFN-g–producing CD4
Th1 lymphocytes toward the cutaneous site of infection. This
conclusion is supported both by histological observation of an
abundance of CD4 T cells in eschars from patients with MSF
and by studies suggesting that RANTES plays a microbicidal
role in certain viral and bacterial infections, including rickett-
sioses [8, 39]. On the other hand, the pathological role of
RANTES could be attributed to expression of a very high level
of the latter, which could substantially increase T cell infiltration
at the site of infection, with subsequent sustained production
of excessive amounts of proinflammatory cytokines. The latter
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can lead to indirect damage to endothelial cells, leading to the
vascular dysregulation and leakage observed in SFG rickettsial
infections. In support of this hypothesis, it has been shown
that a high concentration of RANTES induces the activation
of T cells in a manner that is usually followed by diverse effects,
including substantial T cell proliferation or apoptosis and the
release of proinflammatory cytokines [40]. A closer examina-
tion of the production of each of these mediators in a time-
course study, as well as identification of the cellular source of
these mediators in large groups of patients with MSF of dif-
ferent degrees of severity, is warranted, to attain a better un-
derstanding of MSF in humans.
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